ATE229804T1 - Antibakterielle carbapeneme, zusammensetzungen und verfahren zur behandlung - Google Patents

Antibakterielle carbapeneme, zusammensetzungen und verfahren zur behandlung

Info

Publication number
ATE229804T1
ATE229804T1 AT98953450T AT98953450T ATE229804T1 AT E229804 T1 ATE229804 T1 AT E229804T1 AT 98953450 T AT98953450 T AT 98953450T AT 98953450 T AT98953450 T AT 98953450T AT E229804 T1 ATE229804 T1 AT E229804T1
Authority
AT
Austria
Prior art keywords
treatment
methods
compositions
carbapenems
antibacterial
Prior art date
Application number
AT98953450T
Other languages
English (en)
Inventor
Timothy A Blizzard
Ronald W Ratcliffe
Original Assignee
Merck & Co Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GBGB9806684.8A external-priority patent/GB9806684D0/en
Application filed by Merck & Co Inc filed Critical Merck & Co Inc
Application granted granted Critical
Publication of ATE229804T1 publication Critical patent/ATE229804T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D477/00—Heterocyclic compounds containing 1-azabicyclo [3.2.0] heptane ring systems, i.e. compounds containing a ring system of the formula:, e.g. carbapenicillins, thienamycins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulphur-containing hetero ring
    • C07D477/10—Heterocyclic compounds containing 1-azabicyclo [3.2.0] heptane ring systems, i.e. compounds containing a ring system of the formula:, e.g. carbapenicillins, thienamycins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulphur-containing hetero ring with hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached in position 4, and with a carbon atom having three bonds to hetero atoms with at the most one bond to halogen, e.g. an ester or nitrile radical, directly attached in position 2
    • C07D477/12—Heterocyclic compounds containing 1-azabicyclo [3.2.0] heptane ring systems, i.e. compounds containing a ring system of the formula:, e.g. carbapenicillins, thienamycins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulphur-containing hetero ring with hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached in position 4, and with a carbon atom having three bonds to hetero atoms with at the most one bond to halogen, e.g. an ester or nitrile radical, directly attached in position 2 with hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, attached in position 6
    • C07D477/14—Heterocyclic compounds containing 1-azabicyclo [3.2.0] heptane ring systems, i.e. compounds containing a ring system of the formula:, e.g. carbapenicillins, thienamycins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulphur-containing hetero ring with hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached in position 4, and with a carbon atom having three bonds to hetero atoms with at the most one bond to halogen, e.g. an ester or nitrile radical, directly attached in position 2 with hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, attached in position 6 with hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, attached in position 3
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Communicable Diseases (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Oncology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
AT98953450T 1997-10-15 1998-10-13 Antibakterielle carbapeneme, zusammensetzungen und verfahren zur behandlung ATE229804T1 (de)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US6212197P 1997-10-15 1997-10-15
GBGB9806684.8A GB9806684D0 (en) 1998-03-27 1998-03-27 Carbapenem antibacterial compounds, compositions containing such compounds and ethods of treatment
PCT/US1998/021593 WO1999018954A1 (en) 1997-10-15 1998-10-13 Antibacterial carbapenems, compositions and methods of treatment

Publications (1)

Publication Number Publication Date
ATE229804T1 true ATE229804T1 (de) 2003-01-15

Family

ID=26313381

Family Applications (1)

Application Number Title Priority Date Filing Date
AT98953450T ATE229804T1 (de) 1997-10-15 1998-10-13 Antibakterielle carbapeneme, zusammensetzungen und verfahren zur behandlung

Country Status (7)

Country Link
EP (1) EP1023062B1 (de)
JP (1) JP2001519389A (de)
AT (1) ATE229804T1 (de)
AU (1) AU735124B2 (de)
CA (1) CA2306399A1 (de)
DE (1) DE69810332D1 (de)
WO (1) WO1999018954A1 (de)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2005509608A (ja) * 2001-10-02 2005-04-14 ファルマシア コーポレイション ベンゼンスルホニル化合物の製造方法
NO20053676D0 (no) * 2005-07-29 2005-07-29 Amersham Health As Crystallisation Process

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5756725A (en) * 1996-04-24 1998-05-26 Merck & Co., Inc. Carbapenem antibacterial compounds, compositions containing such compounds and methods of treatment

Also Published As

Publication number Publication date
AU1082499A (en) 1999-05-03
AU735124B2 (en) 2001-06-28
EP1023062B1 (de) 2002-12-18
JP2001519389A (ja) 2001-10-23
WO1999018954A1 (en) 1999-04-22
EP1023062A4 (de) 2001-11-21
EP1023062A1 (de) 2000-08-02
CA2306399A1 (en) 1999-04-22
DE69810332D1 (de) 2003-01-30

Similar Documents

Publication Publication Date Title
MY123354A (en) 4"-substituted-9-deoxo-9a-aza-9a-homoerythromycin a derivatives
DE69410092D1 (en) Phenyl heterocyclen als cyclooxygenase-2 inhibitoren
IL150223A (en) Lipopeptides and pharmaceuticals containing them
DE69716810D1 (de) 2,3-Disubstituierte-(5,6)-heteroarylkondensierte-pyrimidin-4-one
GT199900208A (es) Antibiòticos cetòlidos carbamato y carbazato.
DE69401577T2 (de) Verabreichung von lamotrigin zur behandlung von neuro-aids
DE69917717D1 (de) C11-Carbamate von antibakteriellen Makroliden
FI935777A (fi) AIDSin hoitamisessa käyttökelpoiset HIV-proteaasin inhibiittorit
PT992509E (pt) Novos derivados macrolidos
DE69805305D1 (de) Verwendung von phanquinon zur behandlung von alzheimer's krankheit
HUP0301594A2 (hu) E-metanikotin diacilborkősav sóját tartalmazó gyógyászati készítmények és alkalmazásuk a központi idegrendszer rendellenességeinek kezelésére
DE69514100D1 (de) Substituierte kondensierte und verbrückte bicyclische verbindungen als therapeutische mittel
DE69332366D1 (de) Arylsubstituierte heterocyclische Verbindungen
ATE229804T1 (de) Antibakterielle carbapeneme, zusammensetzungen und verfahren zur behandlung
DE69329184D1 (de) Alkylsubstituierte heterocyclische Verbindungen
ATE274513T1 (de) Verbindungen und verfahren zur behandlung von schmerz
SE9704770D0 (sv) New use
PT952157E (pt) Derivados 9a, 11b-desidro de 9-oxima-3-ceto-6-o-metileritromicina
HK1082727A1 (en) 2" oxo-voruscharin and derivatives thereof

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties